Literature DB >> 29215718

Involvement of Smad3 pathway in atrial fibrosis induced by elevated hydrostatic pressure.

Wei Wei1,2, Fang Rao1,2,3, Fangzhou Liu1,2, Yumei Xue1,2, Chunyu Deng2,3, Zhaoyu Wang2,3, Jiening Zhu2,3, Hui Yang2,3, Xin Li1,2, Mengzhen Zhang2,3, Yongheng Fu2,3, Wensi Zhu2,3, Zhixin Shan2,3, Shulin Wu1,2.   

Abstract

Hypertension is a main risk factor for atrial fibrillation, but the direct effects of hydrostatic pressure on the atrial fibrosis are still unknown. The present study investigated whether hydrostatic pressure is responsible for atrial fibrosis, and addressed a potential role of the Smad pathway in this pathology. Biochemical assays were used to study regulation and expression of fibrotic factors in spontaneously hypertensive rats (SHRs) and Wistar rats, and in cardiac fibroblasts (CFs) cultured under standard (0 mmHg) and elevated (20, 40 mmHg) hydrostatic pressure. Levels of atrial fibrosis and protein expression of fibrotic factors Col-1A1/-3A1, TGF-β1, and MMP-2 in SHRs' left atrial tissues were higher than those in Wistar rats. Exposure to elevated pressure was associated with the proliferation of CFs. The protein expression of Col-1A1/-3A1, TGF-β1, and MMP-2 in CFs was also up-regulated in a pressure-dependent manner. The proliferation of CFs and increased expressions of fibrotic markers induced by elevated hydrostatic pressure could be reversed by the Smad3 inhibitor naringenin. The activation of Smad3 pathway was also stimulated by elevated hydrostatic pressure. These results demonstrate that CF secretory function and proliferation can be up-regulated by exposure to elevated pressure, and that Smad3 may modulate CF activation induced by high hydrostatic pressure.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Smad3; atrial fibrosis; cardiac fibroblasts; hydrostatic pressure; spontaneously hypertensive rats

Mesh:

Substances:

Year:  2018        PMID: 29215718     DOI: 10.1002/jcp.26337

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  7 in total

Review 1.  Invasive therapies for patients with concomitant heart failure and atrial fibrillation.

Authors:  Wei Wei; Michael Shehata; Xunzhang Wang; Fang Rao; Xianzhan Zhan; Huiming Guo; Xianhong Fang; Hongtao Liao; Jian Liu; Hai Deng; Yang Liu; Yumei Xue; Shulin Wu
Journal:  Heart Fail Rev       Date:  2019-09       Impact factor: 4.214

Review 2.  Clinical Evidence and Proposed Mechanisms of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure with Preserved Ejection Fraction: A Class Effect?

Authors:  Brent Deschaine; Sahil Verma; Hussein Rayatzadeh
Journal:  Card Fail Rev       Date:  2022-06-29

3.  Spleen Tyrosine Kinase (SYK) in the Progression of Peritoneal Fibrosis Through Activation of the TGF-β1/Smad3 Signaling Pathway.

Authors:  Kang-Han Liu; Nan Zhou; Yan Zou; Yi-Ya Yang; Sha-Xi OuYang; Yu-Mei Liang
Journal:  Med Sci Monit       Date:  2019-12-08

Review 4.  Naringenin: A Promising Therapeutic Agent against Organ Fibrosis.

Authors:  Yanfei Du; Jun Ma; Yu Fan; Xinyu Wang; Shuzhan Zheng; Jian Feng; Jiafu Li; Zhongcai Fan; Guang Li; Qiang Ye
Journal:  Oxid Med Cell Longev       Date:  2021-11-11       Impact factor: 6.543

Review 5.  Emerging roles of ferroptosis in cardiovascular diseases.

Authors:  Kai Wang; Xin-Zhe Chen; Yun-Hong Wang; Xue-Li Cheng; Yan Zhao; Lu-Yu Zhou; Kun Wang
Journal:  Cell Death Discov       Date:  2022-09-20

6.  Investigating gene-microRNA networks in atrial fibrillation patients with mitral valve regurgitation.

Authors:  Joana Larupa Santos; Ismael Rodríguez; Morten S Olesen; Bo Hjorth Bentzen; Nicole Schmitt
Journal:  PLoS One       Date:  2020-05-11       Impact factor: 3.240

7.  Cellular contribution to left and right atrial dysfunction in chronic arterial hypertension in pigs.

Authors:  Ge Jin; Martin Manninger; Gabriel Adelsmayr; Michael Schwarzl; Alessio Alogna; Patrick Schönleitner; David Zweiker; Florian Blaschke; Mohammad Sherif; Snjezana Radulovic; Paulina Wakula; Sylvia Schauer; Gerald Höfler; Ursula Reiter; Gert Reiter; Heiner Post; Daniel Scherr; Karoly Acsai; Gudrun Antoons; Burkert Pieske; Frank R Heinzel
Journal:  ESC Heart Fail       Date:  2020-11-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.